US › Healthcare

CeriBell, Inc (CBLL)

US · Healthcare · Medical Devices

$18.52+1.15%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$26.5M
Revenue YoY
+29.3%
Net profit
$-19.7M
Profit YoY
-54.5%
EPS
$-0.38
EPS estimate
$-0.39
Net margin
-74.5%

EPS came in at -0.38 against a street estimate of -0.39 — a beat of 2.6%.

Key statistics

Market cap
$694.7M
Forward P/E
0.0
P/B
4.77
Book value
$3.72
EPS (TTM)
$-1.62
52-week high
$24.33
52-week low
$10.85
50-day MA
$18.53
200-day MA
$18.48

Analyst view

Analysts rate CeriBell, Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $26.86.

Shareholding

Insiders
12.79%
Institutions
86.87%

Largest institutional holders

FundStake
FMR Inc12.78%
TPG GP A, LLC10.46%
Red Tree Management, LLC5.81%
BlackRock Inc4.78%
Vanguard Group Inc3.97%
KCM Capital Inc3.69%
Bank of New York Mellon Corp3.06%
Vanguard Capital Management, LLC3.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CeriBell, Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.